Interpace Biosciences (OTCMKTS:IDXG – Get Free Report) released its quarterly earnings results on Monday. The business services provider reported ($0.26) EPS for the quarter, Zacks reports. Interpace Biosciences had a return on equity of 145.40% and a net margin of 67.64%. The business had revenue of $10.37 million for the quarter.
Interpace Biosciences Price Performance
IDXG stock traded down $0.52 during trading hours on Wednesday, reaching $5.48. The stock had a trading volume of 1,600 shares, compared to its average volume of 1,755. The stock has a 50-day simple moving average of $6.40 and a 200 day simple moving average of $8.05. The stock has a market capitalization of $30.37 million, a PE ratio of 13.70 and a beta of 0.67. Interpace Biosciences has a fifty-two week low of $4.95 and a fifty-two week high of $7.45.
Interpace Biosciences Company Profile
Featured Articles
- Five stocks we like better than Interpace Biosciences
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
Receive News & Ratings for Interpace Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interpace Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
